1. Home
  2. KODK vs PRME Comparison

KODK vs PRME Comparison

Compare KODK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$8.05

Market Cap

834.8M

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.93

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
PRME
Founded
1880
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
834.8M
666.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
KODK
PRME
Price
$8.05
$3.93
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$6.42
AVG Volume (30 Days)
1.1M
3.7M
Earning Date
11-06-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,045,000,000.00
$5,977,000.00
Revenue This Year
N/A
$111.80
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
647.13
52 Week Low
$4.93
$1.11
52 Week High
$9.96
$6.94

Technical Indicators

Market Signals
Indicator
KODK
PRME
Relative Strength Index (RSI) 44.12 54.52
Support Level $7.96 $3.29
Resistance Level $8.69 $4.17
Average True Range (ATR) 0.34 0.23
MACD -0.12 0.05
Stochastic Oscillator 5.53 73.30

Price Performance

Historical Comparison
KODK
PRME

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: